The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Impact on carnitine homeostasis of short-term treatment with the pivalate prodrug cefditoren pivoxil
Abstract
BACKGROUND: Pivalate-generating prodrugs have been suggested to cause clinically significant hypocarnitinemia. To evaluate the effect of pivalate prodrug treatment on carnitine homeostasis, we administered a pivalate prodrug, cefditoren pivoxil, to healthy subjects and performed carnitine balance studies. METHODS: Cefditoren pivoxil was administered in one of two dosing regimens (200 mg cefditoren twice daily for 10 days or 400 mg cefditoren twice daily for 14 days) to gender-balanced groups of 15 subjects. Plasma and urine concentrations of carnitine, acetylcarnitine, pivaloylcarnitine, and total carnitine were quantified before, during, and after treatment. RESULTS: Plasma carnitine concentrations fell during cefditoren pivoxil dosing. The nadir in carnitine concentration was dependent on the dose of cefditoren and subject gender (decrease from 44.8 +/- 10.9 micromol/L to 9.2 +/- 1.9 micromol/L in male patients and from 32.5 +/- 5.4 micromol/L to 6.3 +/- 1.7 micromol/L in female patients after 14 days of 400 mg cefditoren twice daily). Urinary elimination of pivaloylcarnitine resulted in a marked increase in total carnitine excretion, as well as net losses of total carnitine of approximately 4.6 mmol with the 200-mg, 10-day regimen and up to 14.9 mmol with the 400-mg, 14-day regimen. Pivaloylcarnitine was the dominant form of excreted pivalate. DISCUSSION: Short-term administration of cefditoren pivoxil results in hypocarnitinemia and increased net losses of total carnitine. It is estimated that net carnitine losses were only 10% of body stores, even with the highest dose regimen tested. Losses of this magnitude would not be anticipated to result in adverse clinical effects.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Other clinical factors that disrupt carnitine status include renal dysfunction and use of drugs that form carnitine conjugates (32,33).”
From Carnitine insufficiency caused by aging and overnutrition compromises mitochondrial performance and metabolic control (2009) · cites this paper as [33]
Citations
Cites
Carnitine—metabolism and functions
Bremer, J. (1983) · Physiological Reviews · doi:10.1152/physrev.1983.63.4.1420 · Cited by 1,666 · cited 1×
“Carnitine plays several important roles in normal intermediary metabolism, including as an obligate for the mitochondrial oxidation of fatty acids.(10) Carnitine is derived from both biosynthesis and dietary sources, but the turnover of the body pool is relatively slow.”
BackgroundCARNITINE METABOLISM AND ITS REGULATION IN MICROORGANISMS AND MAMMALS
Rebouche, C. J., & Seim, H. (1998) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.18.1.39 · Cited by 362 · cited 1×
“Carnitine is derived from both biosynthesis and dietary sources, but the turnover of the body pool is relatively slow.(11,12) From Harbor-UCLA Center for Clinical Pharmacology, Torrance;”
BackgroundKahn, J. (1999) · JAMA · doi:10.1001/jama.282.24.2305 · Cited by 199
CARNITINE DEFICIENCY INDUCED BY PIVAMPICILLIN AND PIVMECILLINAM THERAPY
Holme, E., Jacobson, C.-E., Nordin, I., Greter, J., Lindstedt, S., Kristiansson, B., & Jodal, U. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92086-2 · Cited by 170
Primary systemic carnitine dehciency. II. Renal handling of carnitine
Engel, A. G., Rebouche, C. J., Wilson, D. M., Glasgow, A. M., Romshe, C. A., & Cruse, R. P. (1981) · Neurology · doi:10.1212/wnl.31.7.819 · Cited by 146
Turnover of carnitine by rat tissues
Brooks, D. E., & McIntosh, J. E. A. (1975) · Biochemical Journal · doi:10.1042/bj1480439 · Cited by 123
GENETIC DISORDERS OF CARNITINE METABOLISM AND THEIR NUTRITIONAL MANAGEMENT
Kerner, J., & Hoppel, C. L. (1998) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.18.1.179 · Cited by 115
Carnitine metabolism in normal-weight and obese human subjects during fasting
Hoppel, C. L., & GENUTH, S. M. (1980) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1980.238.5.e409 · Cited by 111
Pharmacokinetic considerations for the therapeutic use of carnitine in hemodialysis patients
Brass, E. (1995) · Clinical Therapeutics · doi:10.1016/0149-2918(95)80017-4 · Cited by 107 · cited 1×
“83 mmol/kg.(24) Thus, on the basis of the average values, male subjects lost 3% and female patients 4% of their total body carnitine after 10 days of 200-mg twice-daily cefditoren use.”
BackgroundSelf-citationPivampicillin-promoted excretion of pivaloylcarnitine in humans
Melegh, B., Kerner, J., & BIEBER, L. L. (1987) · Biochemical Pharmacology · doi:10.1016/0006-2952(87)90318-2 · Cited by 101
Cited by
Carnitine: a nutritional, biosynthetic, and functional perspective
STEIBER, A. (2004) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2004.06.006 · Cited by 446
Enzymes involved in the bioconversion of ester-based prodrugs
Liederer, B. M., & Borchardt, R. T. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20542 · Cited by 377
Noland, R. C., Koves, T. R., Seiler, S. E., Lum, H., Lust, R. M., Ilkayeva, O., Stevens, R. D., Hegardt, F. G., & Muoio, D. M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.032888 · Cited by 317
Tamai, I. (2013) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.1816 · Cited by 141
Metadata
- Authors
- Brass, E.
- Affiliations
- University of California, Los Angeles (US)
- Corresponding author
- Brass, E
- ORCID
- Brass, E
- Venue
- Clinical Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2003-04
- Volume
- 73
- Issue
- 4
- Pages
- 338-347
- ISSN
- 0009-9236 (ISSN-L)
- OpenAlex
- W2006024908
- Cited by
- 50
- References
- 36
- Citations by year
- 2026: 1 · 2025: 3 · 2023: 1 · 2022: 1 · 2021: 3 · 2020: 1 · 2019: 1 · 2017: 1 · 2016: 2 · 2015: 5 · 2013: 3 · 2012: 2
- FWCI
- 2.36
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Pharmacology & Therapeutics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Keywords
- cefditoren pivoxil, carnitine homeostasis, urinary carnitine excretion, acetyl-L-carnitine, plasma carnitine, dose-dependent effects, sex differences, cephalosporin adverse effects
- MeSH terms
- Adult, Carnitine, Cephalosporins, Chromatography, High Pressure Liquid, Drug Administration Schedule, Female, Homeostasis, Humans, Male, Gas Chromatography-Mass Spectrometry, Metabolic Clearance Rate, Middle Aged, Prodrugs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Impact on carnitine homeostasis of short-term treatment with the pivalate prodrug cefditoren pivoxil. https://app.cochat.ai/papers/10.1016/s0009-9236(02)17636-3
- The paper
- Brass, E. (2003). Impact on carnitine homeostasis of short-term treatment with the pivalate prodrug cefditoren pivoxil. Clinical Pharmacology & Therapeutics. https://doi.org/10.1016/s0009-9236(02)17636-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.